HEPATOBILIARY NEOPLASM

HEPATOBILIARY NEOPLASM was reported 10 times

HEPATOBILIARY NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] 1 0.0017
1 Bispecific CD20-directed CD3 T Cell Engager [EPC] 1 0.0002
2 Lipid-based Polyene Antifungal [EPC] 1 0.0001
3 Vitamin D3 Analog [EPC] 1 0.0000
4 Polyene Antifungal [EPC] 1 0.0000
5 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
6 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
7 Corticosteroid [EPC] 1 0.0000